ConductScience.org, home

Paper2226482

Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.

Carbon C. Eur J Clin Microbiol Infect Dis, 1990. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage. Papers, record 2226482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2226482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.
PubMed
Journal
Eur J Clin Microbiol Infect Dis
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carbon CC

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Drug Evaluation, PreclinicalMajor topic
Animals
Bacterial Infections
Dose-Response Relationship, Drug
Humans
Microbial Sensitivity Tests
Tissue Distribution

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16330835Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison.Rev Infect Dis1984https://conductscience.org/library/papers/6330835PubMed
2789324Bacampicillin in acute exacerbations of chronic bronchitis--a dose-range study.J Antimicrob Chemother1976https://conductscience.org/library/papers/789324PubMed
37050257Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.J Infect Dis1982https://conductscience.org/library/papers/7050257PubMed
53324957Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3324957PubMed
63162413Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.Chemotherapy1988https://conductscience.org/library/papers/3162413PubMed
76280599Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6280599PubMed
83540140Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.J Infect Dis1987https://conductscience.org/library/papers/3540140PubMed
93518994Tissue penetration of antibiotics.Clin Biochem1986https://conductscience.org/library/papers/3518994PubMed
103537452Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis.Kidney Int1986https://conductscience.org/library/papers/3537452PubMed
117319989The antibacterial effects of low concentrations of antibiotics and host defence factors: a review.J Antimicrob Chemother1981https://conductscience.org/library/papers/7319989PubMed
123878128Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3878128PubMed
141185015Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.J Infect Dis1975https://conductscience.org/library/papers/1185015PubMed
152942488Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.Infection1986https://conductscience.org/library/papers/2942488PubMed
163324962Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3324962PubMed
174362999Binding of antibiotics to a soluble protein from rat liver.J Infect Dis1974https://conductscience.org/library/papers/4362999PubMed
193938828Increased nephrotoxicity of gentamicin in pyelonephritic rats.Kidney Int1985https://conductscience.org/library/papers/3938828PubMed
206827150Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.J Infect Dis1983https://conductscience.org/library/papers/6827150PubMed
214375433Interaction of purulent material with antibiotics used to treat Pseudomonas infections.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4375433PubMed
222644371Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.J Infect Dis1989https://conductscience.org/library/papers/2644371PubMed
233137272Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.J Infect Dis1988https://conductscience.org/library/papers/3137272PubMed

See all 38 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
15015030Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.Eur J Clin Microbiol Infect Dis2004https://conductscience.org/library/papers/15015030PubMed
12162760Clinical role of protein binding of quinolones.Clin Pharmacokinet2002https://conductscience.org/library/papers/12162760PubMed
10428911Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10428911PubMed
7843184Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476).Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/7843184PubMed
1929323Animal models in the evaluation of antimicrobial agents.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1929323PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2226482

GET https://conductscience.org/api/papers/v1/2226482/references?page=2